scholarly journals A Systematic Review: Topical Sucralfate for Burn Wound

2021 ◽  
Vol 9 (F) ◽  
pp. 516-522
Author(s):  
Loelita Lumintang ◽  
Made S. Adnyana ◽  
I. Nyoman Putu Riasa ◽  
Anak Agung Gde Ngurah Asmarajaya ◽  
Agus Roy Hamid ◽  
...  

BACKGROUND: Topical sucralfate has been used for burn and non-burn skin and mucosal lesion with remarkable results. The healing rate of mucosa is faster than skin lesion. AIM: A current systematic review was conducted to objectively evaluate wound healing benefits of topical sucralfate for burn wound and to show on which degree of burn wound it works compare with another topical agents of burn wound therapy. METHODS: Databases were searched for relevant studies: Google Scholar, PUBMED, and ProQuest. Data sources were searched using MeSH terms: “topical sucralfate” and “burn wound” for all publications up to December 2018. All English papers were included. Only studies performed in humans were included in this study. A total of 2437 publications were found, of which 3 studies met the inclusion criteria and were relevant to be used in this systematic review. The primary outcome was burn wound healing. DATA EXTRACTION: Data from retrieved studies were reviewed and tabulated according to year of publication, study design, human or animal studies, characteristics of the population, and outcomes. DATA SYNTHESIS: A total of 2 randomized controlled trials (RCTs) and 1 observational comparative study were found. All trials are on second degree burn wound patients. Jadad score was used to assess the methodological quality of the RCTs. One RCT and one comparative study demonstrated favorable outcomes with the use of topical sucralfate. There is one publication with no significant differences. CONCLUSIONS: This systematic review shows a noticeably beneficial effect of topical sucralfate for burn wound. It is better than other topical agent in wound healing rate, decreased infection rate and enhancement of epithelialization also granulation with no local or systemic adverse reactions. However, multicenter RCT with larger sample size are needed to make recommendation for burn wound treatment.

2021 ◽  
Vol 39 (7) ◽  
pp. 439-452
Author(s):  
Naira Figueiredo Deana ◽  
Nilton Alves ◽  
Carlos Zaror ◽  
Mariano del Sol ◽  
Vanderlei Salvador Bagnato

Burns ◽  
2007 ◽  
Vol 33 (6) ◽  
pp. 713-718 ◽  
Author(s):  
Ratree Maenthaisong ◽  
Nathorn Chaiyakunapruk ◽  
Surachet Niruntraporn ◽  
Chuenjid Kongkaew

Burns ◽  
2019 ◽  
Vol 45 (5) ◽  
pp. 1014-1023 ◽  
Author(s):  
Ali R. Ahmadi ◽  
Maria Chicco ◽  
Jinny Huang ◽  
Le Qi ◽  
James Burdick ◽  
...  

2015 ◽  
Vol 13 (5) ◽  
pp. 791-798
Author(s):  
Thittamaranahalli M Honnegowda ◽  
Pramod Kumar ◽  
Echalasara G Padmanabha Udupa ◽  
Anurag Sharan ◽  
Rekha Singh ◽  
...  

Author(s):  
Jayshree Shriram Dawane ◽  
Anand Biradar ◽  
Ketan Vaidya ◽  
Ashutosh Sharma ◽  
Madhura Bhosale ◽  
...  

Author(s):  
Sritharadol Rutthapol ◽  
Chunhachaichana Charisopon ◽  
Kumlungmak Sukanjana ◽  
Buatong Wilaiporn ◽  
Dechraksa Janwit ◽  
...  

ABSTRACT This study evaluated the effect of mupirocin topical spray on burn wound healing in a rat model. Fifteen male Sprague Dawley rats were used to create full-thickness burns on the rat dorsum using a cylindrical stainless steel rod. The rats were topically treated with normal saline solution (NSS), mupirocin spray, ointment, and solution. The wound size and morphological evaluation were investigated by photographs and clinical criterions for wound healing. The histology was observed by hematoxylin and eosin (HandE) staining assay. The immunohistochemical study was evaluated by detection of transforming growth factor-beta 1 (TGF-β1), and the ratio of matrix metalloproteinase-9 to the tissue inhibitor of matrix metalloproteinase-1 (MMP-9/TIMP-1) was quantified using the enzyme-linked immunosorbent assay (ELISA) assay. A complete healing was observed at 28 days in all treatments. Mupirocin formulations accelerated the wound healing faster than NSS in size. However, the clinical criteria indicated a desirable skin appearance in the mupirocin spray and ointment treated groups. The histological evaluations showed no differences between the treatments while the immunohistochemical study revealed that all treatments reduced the level of TGF-β1 over time, particularly on day 28 in the mupirocin spray and ointment treated groups. The MMP-9/TIMP-1 ratio was significantly lower in the mupirocin spray and ointment treated groups than in the NSS and mupirocin solution groups. This study shows the safety and efficacy in the use of mupirocin topical spray. The topical mupirocin spray is an alternative suitable for development as a human topical anti-infective and wound protection spray.


Sign in / Sign up

Export Citation Format

Share Document